COVID-19 (2019-nCoV) Nucleic Acid Detection Reagent Kit (Fluorescent PCR Method)

SARS-CoV-2 Nucleic Acid Detection Kit using fluorescent PCR method for rapid and accurate identification of COVID-19 infection. The kit enables qualitative detection of viral RNA in respiratory specimens, supporting clinical diagnosis and epidemiological surveillance. Designed for laboratory use with high sensitivity and specificity.

A diagnostic test kit for detecting SARS-CoV-2 (2019-nCoV) nucleic acids using the RNA capture probe methodology. The kit is designed for COVID-19 screening and diagnosis in clinical laboratory settings.

A diagnostic test kit for detecting SARS-CoV-2 (2019-nCoV) RNA using the capture probe method. This kit is included in the respiratory infection series for COVID-19 clinical diagnosis.

Molecular diagnostic kit specifically designed for detecting novel influenza A H1N1 (2009) virus nucleic acids. Provides auxiliary diagnosis of H1N1 infection in clinical specimens.

Rapid antigen detection kit for SARS-CoV-2 using colloidal gold immunochromatography. Delivers qualitative results for COVID-19 diagnosis in clinical and point-of-care settings. Designed for swift patient screening and laboratory confirmation protocols.

This kit is used for auxiliary diagnosis of diseases caused by Middle East respiratory syndrome coronavirus.

Molecular diagnostic kit for detecting Neisseria gonorrhoeae nucleic acids using PCR technology. Supports epidemiological surveillance and monitoring of sexually transmitted diseases.

This kit is used for auxiliary diagnosis of new influenza A virus H1N1 (2009) infections.

A diagnostic test kit for the detection of hepatitis C virus nucleic acid using fluorescent PCR methodology. This kit is designed for laboratory use in identifying HCV infection through nucleic acid amplification.

PCR fluorescent probe-based nucleic acid detection kit for adenovirus identification. This in vitro diagnostic test enables rapid and accurate detection of adenoviral nucleic acids in clinical specimens using real-time PCR methodology, supporting respiratory and gastrointestinal infection diagnosis.

This kit is used for auxiliary diagnosis of influenza A virus H1N1 (2009) subtype infections.

An in vitro qualitative diagnostic test kit for detecting COVID-19 antigen N protein in human nasal, nasopharyngeal, and oropharyngeal samples using colloidal gold solid-phase immunochromatography. The kit uses a double antibody sandwich immunoassay principle with a test cassette, swabs, extraction tube, and buffer solution. Results are interpreted within 15 minutes by observing colored bands at control and test lines on the cassette. The kit is intended as a supplementary or auxiliary diagnostic indicator and requires confirmation of positive results; negative results do not exclude infection possibility.